Clinical Trial Update: Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 study of NX-5948 in combination with other agents for adults with B-cell malignancies. The trial is currently no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• NX-5948

Snippet

Sponsor: Nurix Therapeutics, Inc. | Conditions: B-cell Lymphoma, Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING